STOCK TITAN
  1. Home
  2. Sec-filings
  3. BSX
  4. [Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity

Boston Scientific (BSX) EVP manages tax on 1,802 RSU vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Boston Scientific EVP Padraig Andrew O'Connor reported routine equity compensation activity involving restricted stock units. On May 2, 2026, he exercised awards covering 1,802 restricted stock units, receiving the same number of shares of Boston Scientific common stock.

To satisfy tax obligations related to this vesting, 872 common shares were disposed of at $56.50 per share through a tax-withholding transaction, which is not an open-market sale. Following these transactions, O'Connor directly holds 7,896 shares of common stock.

Positive

  • None.

Negative

  • None.
Insider O'Connor Padraig Andrew
Role EVP, Global Operations
Type Security Shares Price Value
Exercise Restricted Stock Units 1,802 $0.00 --
Exercise Common Stock 1,802 $0.00 --
Tax Withholding Common Stock 872 $56.50 $49K
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 7,896 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.
RSUs exercised 1,802 units/shares Restricted stock units converted to common stock on May 2, 2026
Tax-withholding shares 872 shares Common shares disposed in tax-withholding transaction at $56.50
Tax-withholding price $56.50 per share Value applied to 872-share tax-withholding disposition
Shares held after transactions 7,896 shares Direct common stock holdings following Form 4 transactions
Restricted Stock Units financial
"Each restricted stock unit represents the Company's commitment to issue one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Common Stock financial
"Shares of common stock will be issued to the reporting person in four equal annual installments"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
O'Connor Padraig Andrew
(Last)(First)(Middle)
300 BOSTON SCIENTIFIC WAY
(Street)
MARLBOROUGH MASSACHUSETTS 01752-1234
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, Global Operations
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/02/2026M1,802A$0.0000(1)7,896D
Common Stock05/02/2026F872D$56.57,024D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)05/02/2026M1,802 (2)05/02/2026(2)Common Stock1,802$0.00000.0000D
Explanation of Responses:
1. Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
2. Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.
/s/ Susan Thompson, Attorney-in-Fact05/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Boston Scientific (BSX) EVP Padraig O'Connor report in this Form 4?

Padraig O'Connor reported routine equity compensation activity. He exercised 1,802 restricted stock units into common stock and had 872 shares withheld to cover taxes, ending with 7,896 Boston Scientific common shares held directly.

How many Boston Scientific (BSX) shares did the EVP acquire through RSU vesting?

The EVP acquired 1,802 shares of Boston Scientific common stock through the exercise of restricted stock units. Each unit represented a commitment to issue one share, converting on May 2, 2026, as part of his long-term equity compensation package.

Were any of the Boston Scientific (BSX) shares in this Form 4 sold on the open market?

No open-market sale is reported. The 872-share disposition is labeled as a tax-withholding transaction, meaning shares were withheld to pay tax obligations on vested awards, rather than being sold at the insider’s discretion in the open market.

How many Boston Scientific (BSX) shares does the EVP hold after these transactions?

After the reported transactions, Padraig O'Connor directly holds 7,896 shares of Boston Scientific common stock. This figure reflects his position following the RSU exercise and the 872-share tax-withholding disposition disclosed in the Form 4 filing.

What price per share was used for the Boston Scientific (BSX) tax-withholding transaction?

The 872 shares used for tax withholding were valued at $56.50 per share. This price is applied within the tax-related disposition to cover the exercise price or tax liability arising from the vesting of restricted stock unit awards.